Compare PLETHICO PHARMA with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA TTK HEALTHCARE PLETHICO PHARMA/
TTK HEALTHCARE
 
P/E (TTM) x -1.1 19.3 - View Chart
P/BV x 0.0 1.5 1.1% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 PLETHICO PHARMA   TTK HEALTHCARE
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
TTK HEALTHCARE
Mar-19
PLETHICO PHARMA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs3951,215 32.5%   
Low Rs31610 5.1%   
Sales per share (Unadj.) Rs604.4444.4 136.0%  
Earnings per share (Unadj.) Rs32.517.2 188.3%  
Cash flow per share (Unadj.) Rs51.327.6 185.8%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs473.6177.9 266.1%  
Shares outstanding (eoy) m34.0814.13 241.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.42.1 17.2%   
Avg P/E ratio x6.652.9 12.4%  
P/CF ratio (eoy) x4.233.0 12.6%  
Price / Book Value ratio x0.55.1 8.8%  
Dividend payout %029.0 0.0%   
Avg Mkt Cap Rs m7,26212,894 56.3%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m1,5961,307 122.1%   
Avg. sales/employee Rs ThNM2,715.7-  
Avg. wages/employee Rs ThNM565.3-  
Avg. net profit/employee Rs ThNM105.4-  
INCOME DATA
Net Sales Rs m20,5986,279 328.1%  
Other income Rs m38678 498.5%   
Total revenues Rs m20,9846,356 330.1%   
Gross profit Rs m2,818496 568.5%  
Depreciation Rs m642147 437.8%   
Interest Rs m1,59334 4,713.6%   
Profit before tax Rs m969393 246.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138149 -92.9%   
Profit after tax Rs m1,107244 454.2%  
Gross profit margin %13.77.9 173.3%  
Effective tax rate %-14.337.9 -37.7%   
Net profit margin %5.43.9 138.5%  
BALANCE SHEET DATA
Current assets Rs m18,8772,717 694.7%   
Current liabilities Rs m11,8961,571 757.3%   
Net working cap to sales %33.918.3 185.6%  
Current ratio x1.61.7 91.7%  
Inventory Days Days3632 111.8%  
Debtors Days Days19847 424.0%  
Net fixed assets Rs m9,861991 995.0%   
Share capital Rs m341141 241.1%   
"Free" reserves Rs m12,3312,373 519.6%   
Net worth Rs m16,1392,514 641.9%   
Long term debt Rs m4,7063 138,405.9%   
Total assets Rs m33,1464,158 797.1%  
Interest coverage x1.612.6 12.7%   
Debt to equity ratio x0.30 21,562.8%  
Sales to assets ratio x0.61.5 41.2%   
Return on assets %8.16.7 122.1%  
Return on equity %6.99.7 70.8%  
Return on capital %12.316.9 72.6%  
Exports to sales %21.43.6 595.9%   
Imports to sales %15.20.5 3,088.6%   
Exports (fob) Rs m4,402225 1,954.9%   
Imports (cif) Rs m3,13631 10,132.5%   
Fx inflow Rs m4,402225 1,954.9%   
Fx outflow Rs m3,18471 4,477.4%   
Net fx Rs m1,219154 790.8%   
CASH FLOW
From Operations Rs m2,437173 1,408.1%  
From Investments Rs m-6,26597 -6,491.9%  
From Financial Activity Rs m2,490-307 -810.3%  
Net Cashflow Rs m-1,337-38 3,546.8%  

Share Holding

Indian Promoters % 82.7 65.4 126.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 3.7 116.2%  
FIIs % 5.5 5.2 105.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 25.8 29.1%  
Shareholders   10,665 12,723 83.8%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   DR. DATSONS LABS  BIOCON   FULFORD INDIA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare PLETHICO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Rally; Sensex Zooms 1,250 Points(12:30 pm)

Share markets in India are presently trading on a strong note, cheering the government's move to cut corporate tax rates to boost economic growth.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

My 7 Stocks to Buy Are Companies Which Will Be a Big Part of New India(The 5 Minute Wrapup)

Sep 19, 2019

The India we knew is changing. Here's how you can benefit from this change.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

Did the Tax Bonanza Really Deserve a 2,000-point Gain on the Sensex?(Profit Hunter)

Sep 20, 2019

Are investors overdoing their euphoria post the corporate tax cut bonanza?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 5-YR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS